Keensight Capital acquired Symeres in 2021 Exemplify BioPharma provides integrated small molecule chemistry manufacturing and controls services to pharmaceutical and biotech partners Symeres is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results